1 reports of this reaction
11.1% of all ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY reports
#9 most reported adverse reaction
SWOLLEN TONGUE is the #9 most commonly reported adverse reaction for ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY, manufactured by The Procter & Gamble Manufacturing Company. There are 1 FDA adverse event reports linking ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY to SWOLLEN TONGUE. This represents approximately 11.1% of all 9 adverse event reports for this drug.
Patients taking ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY who experience swollen tongue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SWOLLEN TONGUE is a frequently reported adverse event for ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY, accounting for a significant proportion of all reports.
In addition to swollen tongue, the following adverse reactions have been reported for ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY:
The following drugs have also been linked to swollen tongue in FDA adverse event reports:
SWOLLEN TONGUE has been reported as an adverse event in 1 FDA reports for ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY. This does not prove causation, but indicates an association observed in post-market surveillance data.
SWOLLEN TONGUE accounts for approximately 11.1% of all adverse event reports for ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY, making it a notable side effect.
If you experience swollen tongue while taking ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.